CN103169850A - Mongolian medicine for treating peptic ulcer - Google Patents
Mongolian medicine for treating peptic ulcer Download PDFInfo
- Publication number
- CN103169850A CN103169850A CN2013101280518A CN201310128051A CN103169850A CN 103169850 A CN103169850 A CN 103169850A CN 2013101280518 A CN2013101280518 A CN 2013101280518A CN 201310128051 A CN201310128051 A CN 201310128051A CN 103169850 A CN103169850 A CN 103169850A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- peptic ulcer
- treatment
- mongolian medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 82
- 208000008469 Peptic Ulcer Diseases 0.000 title claims abstract description 22
- 208000011906 peptic ulcer disease Diseases 0.000 title claims abstract description 21
- 229940079593 drug Drugs 0.000 claims abstract description 18
- 235000011517 Terminalia chebula Nutrition 0.000 claims abstract description 7
- 241000935235 Fritillaria meleagris Species 0.000 claims abstract description 3
- 241000382455 Angelica sinensis Species 0.000 claims abstract 6
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract 4
- 244000277583 Terminalia catappa Species 0.000 claims abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 239000012153 distilled water Substances 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 14
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 244000247747 Coptis groenlandica Species 0.000 claims description 6
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 239000004575 stone Substances 0.000 claims description 6
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 claims description 3
- 229940093265 berberine Drugs 0.000 claims description 3
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 241000238413 Octopus Species 0.000 claims 6
- 241000605372 Fritillaria Species 0.000 claims 5
- 239000001359 coriandrum sativum l. oleoresin Substances 0.000 claims 4
- 241000125175 Angelica Species 0.000 claims 2
- 240000000467 Carum carvi Species 0.000 claims 2
- 235000005747 Carum carvi Nutrition 0.000 claims 2
- 235000001287 Guettarda speciosa Nutrition 0.000 claims 2
- 240000001194 Heliotropium europaeum Species 0.000 claims 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims 2
- 239000003205 fragrance Substances 0.000 claims 2
- 244000119298 Emblica officinalis Species 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 210000003608 fece Anatomy 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 241000037740 Coptis chinensis Species 0.000 abstract description 2
- 241000301400 Trogopterus Species 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 abstract description 2
- 239000010440 gypsum Substances 0.000 abstract description 2
- 229910052602 gypsum Inorganic materials 0.000 abstract description 2
- 231100000614 poison Toxicity 0.000 abstract description 2
- 244000116484 Inula helenium Species 0.000 abstract 1
- 235000002598 Inula helenium Nutrition 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 239000002574 poison Substances 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 210000000582 semen Anatomy 0.000 description 12
- 235000001892 vitamin D2 Nutrition 0.000 description 12
- 208000025865 Ulcer Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 231100000397 ulcer Toxicity 0.000 description 11
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 10
- 239000011653 vitamin D2 Substances 0.000 description 10
- 208000007107 Stomach Ulcer Diseases 0.000 description 9
- 230000002496 gastric effect Effects 0.000 description 9
- 201000005917 gastric ulcer Diseases 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 241000700159 Rattus Species 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 238000010298 pulverizing process Methods 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 241000001522 Terminalia chebula Species 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- 229920001277 pectin Polymers 0.000 description 5
- 235000010987 pectin Nutrition 0.000 description 5
- 239000001814 pectin Substances 0.000 description 5
- 208000037920 primary disease Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 210000004211 gastric acid Anatomy 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 244000272264 Saussurea lappa Species 0.000 description 3
- 235000006784 Saussurea lappa Nutrition 0.000 description 3
- 241000238370 Sepia Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- UJQGVDNQDFTTLZ-VNHYZAJKSA-N 2-[(2r,4ar,8as)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]prop-2-enoic acid Chemical compound C1CCC(=C)[C@@H]2C[C@H](C(=C)C(O)=O)CC[C@]21C UJQGVDNQDFTTLZ-VNHYZAJKSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000037803 Coptis deltoidea Species 0.000 description 2
- 244000018436 Coriandrum sativum Species 0.000 description 2
- 235000002787 Coriandrum sativum Nutrition 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 231100000111 LD50 Toxicity 0.000 description 2
- 241000600550 Lagotis brevituba Species 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 241000301399 Trogopterus xanthipes Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940069428 antacid Drugs 0.000 description 2
- 239000003159 antacid agent Substances 0.000 description 2
- 230000001458 anti-acid effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 230000027119 gastric acid secretion Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- QXRKIZKJLNNMNC-UHFFFAOYSA-N 11,13-Dihydrocostic acid Natural products CC(C1CCC2(C)CCCC(=C)C2C1)C(=O)O QXRKIZKJLNNMNC-UHFFFAOYSA-N 0.000 description 1
- FKWGZOFNSIESOX-QLFBSQMISA-N 2-[(2r,4ar,8as)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]prop-2-en-1-ol Chemical compound C1CCC(=C)[C@@H]2C[C@H](C(=C)CO)CC[C@]21C FKWGZOFNSIESOX-QLFBSQMISA-N 0.000 description 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- WTQYWNWRJNXDEG-UHFFFAOYSA-N 6-Hydroxy-hyoscyamin Natural products CN1C(C2)CC(O)C1CC2OC(=O)C(CO)C1=CC=CC=C1 WTQYWNWRJNXDEG-UHFFFAOYSA-N 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 229910000014 Bismuth subcarbonate Inorganic materials 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- BQENDLAVTKRQMS-SBBGFIFASA-L Carbenoxolone sodium Chemical compound [Na+].[Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)CCC([O-])=O)C1(C)C BQENDLAVTKRQMS-SBBGFIFASA-L 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 241000407877 Combretum Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000786784 Dolomiaea souliei Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241001547127 Fritillaria cirrhosa Species 0.000 description 1
- 241001644297 Fritillaria delavayi Species 0.000 description 1
- 241001644295 Fritillaria przewalskii Species 0.000 description 1
- 241001644290 Fritillaria unibracteata Species 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 241000735432 Hydrastis canadensis Species 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- OVHUAFPHYGFWPY-UHFFFAOYSA-N Imperialin Natural products CC1CN2CC3C(CCC4C3CC5C4CC(=O)C6CC(O)CCC56C)CC2C(C)(O)C1 OVHUAFPHYGFWPY-UHFFFAOYSA-N 0.000 description 1
- IQDIERHFZVCNRZ-YUYPDVIUSA-N Imperialine Chemical compound C([C@@H]1C(=O)C[C@H]2[C@@H]3CC[C@@H]4[C@]5(C)O)[C@@H](O)CC[C@]1(C)[C@H]2C[C@H]3[C@@H]4CN1[C@H]5CC[C@H](C)C1 IQDIERHFZVCNRZ-YUYPDVIUSA-N 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- SGZOYHLQNUSAIL-UHFFFAOYSA-N Ioscostussaeure Natural products C1C(C(=C)C(O)=O)CCC2(C)CCCC(C)=C21 SGZOYHLQNUSAIL-UHFFFAOYSA-N 0.000 description 1
- 241000984131 Lagotis clarkei Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 229910001051 Magnalium Inorganic materials 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000399256 Pteromyini Species 0.000 description 1
- 201000000660 Pyloric Stenosis Diseases 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241001534869 Terminalia Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 241000566916 Tomentella Species 0.000 description 1
- IUKLSMSEHKDIIP-BZMYINFQSA-N Verticine Chemical compound C([C@@H]1[C@@H](O)C[C@H]2[C@@H]3CC[C@@H]4[C@]5(C)O)[C@@H](O)CC[C@]1(C)[C@H]2C[C@H]3[C@@H]4CN1[C@H]5CC[C@H](C)C1 IUKLSMSEHKDIIP-BZMYINFQSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- LCXREBMNASQAOC-UHFFFAOYSA-N Worenine Chemical compound C1=C2C(C)=C(C=3C(=CC=4OCOC=4C=3)CC3)[N+]3=CC2=CC2=C1OCO2 LCXREBMNASQAOC-UHFFFAOYSA-N 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- ICZLJTGFYIBFLM-UHFFFAOYSA-N [Mg].[Ca].[Bi] Chemical compound [Mg].[Ca].[Bi] ICZLJTGFYIBFLM-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- WTQYWNWRJNXDEG-LEOABGAYSA-N anisodamine Chemical compound C1([C@@H](CO)C(=O)O[C@@H]2C[C@H]3[C@@H](O)C[C@@H](C2)N3C)=CC=CC=C1 WTQYWNWRJNXDEG-LEOABGAYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- UTXMCYDEIZPGME-UHFFFAOYSA-N beta-Isocostic acid Natural products C1CC(C(=C)C(O)=O)CC2C(C)=CCCC21C UTXMCYDEIZPGME-UHFFFAOYSA-N 0.000 description 1
- UJQGVDNQDFTTLZ-UHFFFAOYSA-N beta-costic acid Natural products C1CCC(=C)C2CC(C(=C)C(O)=O)CCC21C UJQGVDNQDFTTLZ-UHFFFAOYSA-N 0.000 description 1
- MGLUJXPJRXTKJM-UHFFFAOYSA-L bismuth subcarbonate Chemical compound O=[Bi]OC(=O)O[Bi]=O MGLUJXPJRXTKJM-UHFFFAOYSA-L 0.000 description 1
- 229940036358 bismuth subcarbonate Drugs 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229960000530 carbenoxolone Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 229930016889 costol Natural products 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 1
- 229960001625 furazolidone Drugs 0.000 description 1
- ITRHZWKEZJYJQO-UHFFFAOYSA-N gamma-costol Natural products C1C(C(=C)CO)CCC2(C)CCCC(C)=C21 ITRHZWKEZJYJQO-UHFFFAOYSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 235000005679 goldenseal Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004682 mucosal barrier function Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- IUKLSMSEHKDIIP-UHFFFAOYSA-N petine Natural products CC1(O)C2CCC3C4CC(O)C5CC(O)CCC5(C)C4CC3C2CN2C1CCC(C)C2 IUKLSMSEHKDIIP-UHFFFAOYSA-N 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- -1 pyrenzepine Chemical compound 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical group [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- MNQYNQBOVCBZIQ-JQOFMKNESA-A sucralfate Chemical compound O[Al](O)OS(=O)(=O)O[C@@H]1[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](COS(=O)(=O)O[Al](O)O)O[C@H]1O[C@@]1(COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)O1 MNQYNQBOVCBZIQ-JQOFMKNESA-A 0.000 description 1
- 229960004291 sucralfate Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug, namely a mongolian medicine for treating peptic ulcer. The mongolian medicine is characterized in that the drug is prepared from the following crude drugs in parts by weight: 2-6 parts of kanako, 3-9 parts of angelica sinensis, 2-6 parts of trogopterus dung, 5-12 parts of gypsum rubrum, 5-12 parts of myrobalan, 5-12 parts of cuttlebone, 2-6 parts of bulb of fritillary, 2-6 parts of coptis chinensis and 1-5 parts of elecampane. The anaesthetic has the beneficial effects of being significant in curative effect on the peptic ulcer, short in course of treatment, fast to become effective, free of poison and side effects, easy to obtain materials, simple to prepare, low in cost, convenient to use, and wide in application range. Therefore, the mongolian medicine has high use value and a wide market prospect.
Description
Technical field
The present invention relates to a kind of medicine, i.e. a kind of mongolian medicine for the treatment of peptic ulcer.
Background technology
Peptic ulcer (peptic ulcer) mainly refers to betide the duodenal chronic ulcer of harmonization of the stomach, is a frequently-occurring disease, commonly encountered diseases.The patient shows as epigastrium stomachache and acid regurgitation, belch more, feels sick, vomiting etc., and severe patient can cause the even canceration of gastrointestinal hemorrhage, perforation, pyloric obstruction.At present, the Drug therapy of primary disease adopts antacid, gastric acid secretion inhibitor, gastrointestinal protective agent, antibacterial to treat more.Antacid such as sodium bicarbonate, calcium carbonate, aluminium hydroxide, bismuth subcarbonate, its compound preparation commonly used have that gastropine, magnalium mixture, stomach infections are peaceful, roter tablets, compound calcium bismuth magnesium etc.Gastric acid secretion inhibitor such as Semen daturae, atropine, Anisodamine, pyrenzepine, cimetidine, famotidine, losec etc.Protection medicine such as sucralfate, tripotassium two citron complexation bismuths, carbenoxolone.Antibacterial therapy mainly adopts the medicine of anti-helicobacter pylori, as furazolidone etc.Chinese medicine thinks that primary disease belongs to " gastric abscess " category, generally is divided into Four types: one is spleen-stomach deficiency-cold, and the rule for the treatment of is that during warming the spleen stomach invigorating, QI invigorating are good for, the side of representative is Huangqijianzhongtangas as main prescription; Two is caused by hepatic stagnation qi stagnation, and the rule for the treatment of is depressed liver-energy dispersing and QI regulating and stomach and alleviating pain, and the side of representative is the bupleurum powder for relieving liver-qi plus-minus; Three is type of deficiency of stomach yin, and the rule for the treatment of is nourishing stomach-YIN, and the side of representative is YIGUANJIAN or Ophiopogonis Decoction plus-minus; Four is blood stasis type, and the rule for the treatment of is disperse blood stasis and dredge collateral, and the side of representative is the SHIXIAO SAN plus-minus.Mongolian medicine's mongolian medicine is mainly treated according to bag as disease for peptic ulcer, and the prescription of many determined curative effects is arranged, and mongolian medicine adopts the processing mode that crude drug directly is pulverized and mixed more in addition, and effective ingredient keeps more complete, and therapeutic effect relatively protrudes., owing to lack to collect arranging, many prescriptions only in the mode of maintaining secrecy at folklore, what be seen in ancient books and records only has the minority prescriptions such as Mirabilitum crystallina-21, the Radix Aucklandiae-6.Existing medicine, although peptic ulcer is all had certain curative effect,, exist the drawbacks such as the medicine journey is grown, taken effect slowly, expense is high, side effect is large more, some medicament is limited to lenitive symptomatic treatment, is difficult to radical cure, and relapse rate is high, can not meet patient's demand, can not suppress primary disease situation occurred frequently.
Summary of the invention
The purpose of this invention is to provide and a kind of peptic ulcer is had significant curative effect, and short treating period, instant effect, cure rate is high, cost is low mongolian medicine.
Above-mentioned purpose is realized by following technical scheme: a kind of mongolian medicine for the treatment of peptic ulcer is provided, is characterized in: this medicine is to be made by following crude drug by weight: Semen Coriandri 2-6 part, Radix Angelicae Sinensis 3-9 part, Oletum Trogopterori 2-6 part, Mirabilitum crystallina 5-12 part, Fructus Chebulae 5-12 part, Endoconcha Sepiae 5-12 part, Bulbus Fritillariae Uninbracteatae 2-6 part, Rhizoma Coptidis 2-6 part, Radix Aucklandiae 1-5 part.
The optimization weight portion prescription of said medicine is: 4 parts of Semen Coriandris, 6 parts of Radix Angelicae Sinensis, 4 parts of Oletum Trogopteroris, 9 parts of Mirabilitum crystallinas, 9 parts of Fructus Chebulaes, 9 parts of Endoconcha Sepiaes, 4 parts of Bulbus Fritillariae Uninbracteataes, 4 parts of Rhizoma Coptidis, 3 parts of the Radix Aucklandiae.
The optimization weight portion prescription of said medicine is: Semen Coriandri 2g, Radix Angelicae Sinensis 3g, Oletum Trogopterori 2g, Mirabilitum crystallina 5g, Fructus Chebulae 5g, Endoconcha Sepiae 5g, Bulbus Fritillariae Uninbracteatae 2g, Rhizoma Coptidis 2g, Radix Aucklandiae 1g.
The optimization weight portion prescription of said medicine is: Semen Coriandri 4g, Radix Angelicae Sinensis 6g, Oletum Trogopterori 4g, Mirabilitum crystallina 9g, Fructus Chebulae 9g, Endoconcha Sepiae 9g, Bulbus Fritillariae Uninbracteatae 4g, Rhizoma Coptidis 4g, Radix Aucklandiae 3g.
The optimization weight portion prescription of said medicine is: Semen Coriandri 6g, Radix Angelicae Sinensis 9g, Oletum Trogopterori 6g, Mirabilitum crystallina 12g, Fructus Chebulae 12g, Endoconcha Sepiae 12g, Bulbus Fritillariae Uninbracteatae 6g, Rhizoma Coptidis 6g, Radix Aucklandiae 5g.
The optimization weight portion prescription of said medicine is: Semen Coriandri 2g, Radix Angelicae Sinensis 6g, Oletum Trogopterori 6g, Mirabilitum crystallina 12g, Fructus Chebulae 9g, Endoconcha Sepiae 12g, Bulbus Fritillariae Uninbracteatae 3g, Rhizoma Coptidis 3g, Radix Aucklandiae 2g.
The manufacture method of said medicine is: pulverized 80 orders with top sieve, and made powder or tablet or pill.
The manufacture method of said medicine is: Radix Angelicae Sinensis, Rhizoma Coptidis, Fructus Chebulae are carried out respectively reflux, extract, three times: add for the first time 5ml/g distilled water backflow 1h, add for the second time 3ml/g distilled water backflow 1h, add for the third time 1ml/g distilled water backflow 1h, merge three times extracting solution, after placing the water-bath oven dry, pulverizing obtains water extract, other crude drug were pulverized 100 mesh sieves, mixed with above-mentioned water extract.
The invention has the beneficial effects as follows: peptic ulcer there is significant curative effect, short treating period, instant effect has no side effect, and draws materials easily, makes simply, and is with low cost, easy to use, wide accommodation, thereby have higher use value and wide market prospect.
The specific embodiment
The first embodiment: get by weight crude drug Semen Coriandri 2g, Radix Angelicae Sinensis 3g, Oletum Trogopterori 2g, Mirabilitum crystallina 5g, Fructus Chebulae 5g, Endoconcha Sepiae 5g, Bulbus Fritillariae Uninbracteatae 2g, Rhizoma Coptidis 2g, Radix Aucklandiae 1g, pulverized 80 orders with top sieve, make powder, tablet or pill.Also can with reference to above-mentioned prescription, carry out batch formulation.Radix Angelicae Sinensis, Rhizoma Coptidis, Fructus Chebulae can be carried out respectively reflux, extract, three times, namely add 5ml/g distilled water backflow 1h, then add 3ml/g distilled water backflow 1h, then add 1ml/g distilled water backflow 1h, merge three times extracting solution, place the rear pulverizing of water-bath oven dry.Other crude drug were pulverized 100 mesh sieves, with above-mentioned water extract mix preparation.
Method of administration: 2-3 time on the one, a 3-9g, warm water delivery service.
Since 2008, carried out respectively pharmacology, toxicity, the test of pesticide effectiveness with this side, prove to have no side effect that slight chronic peptic ulcer is had good efficacy.
The second embodiment: get by weight crude drug Semen Coriandri 4g, Radix Angelicae Sinensis 6g, Oletum Trogopterori 4g, Mirabilitum crystallina 9g, Fructus Chebulae 9g, Endoconcha Sepiae 9g, Bulbus Fritillariae Uninbracteatae 4g, Rhizoma Coptidis 4g, Radix Aucklandiae 3g, pulverized 80 orders with top sieve, make powder, tablet or pill.Also can with reference to above-mentioned prescription, carry out batch formulation.Radix Angelicae Sinensis, Rhizoma Coptidis, Fructus Chebulae can be carried out respectively reflux, extract, three times, namely add 5ml/g distilled water backflow 1h, then add 3ml/g distilled water backflow 1h, then add 1ml/g distilled water backflow 1h, merge three times extracting solution, place the rear pulverizing of water-bath oven dry.Other crude drug were pulverized 100 mesh sieves, with above-mentioned water extract mix preparation.
Method of administration: 2-3 time on the one, a 3-9g, warm water delivery service.
The third embodiment: get by weight crude drug Semen Coriandri 6g, Radix Angelicae Sinensis 9g, Oletum Trogopterori 6g, Mirabilitum crystallina 12g, Fructus Chebulae 12g, Endoconcha Sepiae 12g, Bulbus Fritillariae Uninbracteatae 6g, Rhizoma Coptidis 6g, Radix Aucklandiae 5g, pulverized 80 orders with top sieve, make powder, tablet or pill.Also can with reference to above-mentioned prescription, carry out batch formulation.Radix Angelicae Sinensis, Rhizoma Coptidis, Fructus Chebulae can be carried out respectively reflux, extract, three times, namely add 5ml/g distilled water backflow 1h, then add 3ml/g distilled water backflow 1h, then add 1ml/g distilled water backflow 1h, merge three times extracting solution, place the rear pulverizing of water-bath oven dry.Other crude drug were pulverized 100 mesh sieves, with above-mentioned water extract mix preparation.
Method of administration: 2-3 time on the one, a 3-9g, warm water delivery service.
The 4th kind of embodiment: get by weight 2 parts of crude drug Semen Coriandris, 6 parts of Radix Angelicae Sinensis, 6 parts of Oletum Trogopteroris, 12 parts of Mirabilitum crystallinas, 9 parts of Fructus Chebulaes, 12 parts of Endoconcha Sepiaes, 3 parts of Bulbus Fritillariae Uninbracteataes, 3 parts of Rhizoma Coptidis, 2 parts of the Radix Aucklandiae.Pulverize 80 orders with top sieve, made powder, tablet or pill.
Also Radix Angelicae Sinensis, Rhizoma Coptidis, Fructus Chebulae can be carried out respectively reflux, extract, three times, namely add 5ml/g distilled water backflow 1h, then add 3ml/g distilled water backflow 1h, then add 1ml/g distilled water backflow 1h, merge three times extracting solution, place the rear pulverizing of water-bath oven dry.Other crude drug were pulverized 100 mesh sieves, with above-mentioned water extract mix preparation.
Method of administration: 2-3 time on the one, a 3-9g, warm water delivery service.
Experimental analysis
One, prescription analysis: peptic ulcer is a kind of multi-pathogenesis disease, and the theoretical more complicated of relevant this disease of Mongolian medicine be it is generally acknowledged to belong to gastropathy, comprises that the stomach bag is as sick and intestinal bag such as disease.In addition, stomach is conspicuous draws disease, stomach Ba Da to do the symptom such as disease and medication also to exist with primary disease and intersect according to disease, stomach are uncommon.Chinese medicine thinks that primary disease belongs to " gastric abscess " category, generally is divided into spleen-stomach deficiency-cold, caused by hepatic stagnation qi stagnation, type of deficiency of stomach yin, blood stasis type.It is relevant with gastric acid, pepsin, infection, heredity, body constitution, environment, diet, living habit, neural Nervous and Mental Factors etc. that modern medicine is thought, take dysequilibrium between gastric acid, pepsic digestion power and gastric mucosal barrier function and Helicobacter pylori infection as main pathogenic.This medicine is on the basis of a large amount of Mongolian medicine of collection proved recipes, and with reference to Mongolian medicine, the traditional Chinese medical science and modern medical theory, screening forms through great many of experiments.Wherein: Semen Coriandri is the dry mature fruit of samphire coriander (Coriandrum sativum L.), another name Fructus Coriandri, ceriander seed contain volatile oil, fat, saccharide, nitrogen substance, and acrid in the mouth is cool in nature, attach to the lung and stomach meridians, have the effect of regulating gastrointestinal peristalsis and heat-clearing and toxic substances removing.Radix Angelicae Sinensis (Chinese Angelica) is the root of umbelliferae angelica, another name: driedly return, horse hair Radix Angelicae Sinensis, the Qin which, horse hair are returned, cloud is returned, western Radix Angelicae Sinensis, Min Radix Angelicae Sinensis, Mongolian claims DANGGONG, the composition that contains volatile oil and a kind of energy excited uterus, contain again sucrose, vitamin B12 etc., warm in nature, sweet-bitter flavor has antiinflammatory, analgesia, raising immunity and improves the merits such as blood circulation.Oletum Trogopterori (Trogopterus Dung, dung of Complex-toothed Flying Squirrel) be the dry feces of flying squirrel section animal trogopterus xanthipes Milne-Edwards, another name: half congealed Oletum Trogopterori, Oletum Trogopterori, Mongolian claims that Ha Dun-Hai Lumole, Ba Lage are suitable, sweet in flavor and warm in property, contain retinoid material, resin etc., have the effect of promoting blood circulation and stopping pain, removing stasis to stop bleeding, removing food stagnancy detoxifcation, be usually used in treating the stagnant stomachache of the stasis of blood in puerperal, metrostaxis, infantile malnutrition, snakes and scorpions centipete bite etc., usual amounts 6-9g.Mirabilitum crystallina (Caleitum) is the crystal of Sulfates mineral Natrii Sulfas, i.e. calcium carbonate (CaCO
3), another name Mirabilitum crystallina, plain boiled water stone, CALCITUM GYPSUM RUBRUM, salt essence, water stone, BINGSHI, magpie stone, salt essence stone, mud essence, salt pillow, salt root, Mongolian claims Ge Re-Zhong Xi, steeps secondary, Chu Lunei-Tong loud, high-pitched sound clarke, the nature and flavor suffering is salty-cold, can be analgesic, antiinflammatory, relieving constipation, pathogenic fire reducing, sharp key, detumescence, row calentura, accumulated heat excessive thirst, vomiting and diarrhoea, edema, urine retention, bleeding from the gum, erysipelas, scald etc. when being usually used in treating.The Fructus Chebulae calls that chebule, Da Jin fruit, fiber crops come, scold pears, scold multitude, fragrant bavin, microtriche Fructus Chebulae, son with the wind, title " Fructus Chebulae " person is arranged in multiple publication, dry fruit for Combretum Racemosum Terminalia plant terminalia chebula Retz (Terminalia chebula Retz.) or Terminalia chebula Retz. var. tomentella Kurt., my smooth father-in-law's trrellis diagram-ARULA of Mongolia name, Si Ridaoke-ARULA, Pu Lejide-ARULA, puckery is flat, has three of conditionings, suppresses uncommon and draw, restrain wound, granulation promoting, helps digestion, the effect of detoxifcation.Endoconcha Sepiae (Cuttlebone) is tropical off-lying sea property kind, another name: black Quarry bone, sepia bone, Os Sepiae, cuttlebone, cuttlefish lid, Mongolian claims Bai Hetuzha loud, high-pitched sound Song-Ya Su, Bai Hetu-Xi Su loud, high-pitched sound, contain calcium carbonate, calcium phosphate, chitin, colloid, salty in the mouth adstringency temperature, but astringing to arrest bleeding, treating spontaneous emission and leukorrhagia, relieving gastric hyperacidity to alleviate stomachache, removing dampness sore are usually used in treating spitting blood, metrorrhagia, have blood in stool, epistaxis, wound hemorrhage, emission due to deficiency of the kidney spermatorrhea, leucorrhea with red and white discharge, stomachache are noisy, belch pantothenic acid, eczema, ulcer.Bulbus Fritillariae Uninbracteatae (fritillary) is the Liliaceae dry bulb of herbaceous plant Bulbus Fritillariae Thunbergii Fritillaria unibracteata Hsiao et K.C.Hsia or Bulbus Fritillariae Cirrhosae F.cirrhosa D.Don, Bulbus Fritillariae cirrhosae F.delavayi Fr., Gansu Bulbus Fritillariae Uninbracteatae F.przewalskii Maxim.ex.Batalin for many years, another name: Bulbus Fritillariae Thunbergii, pearl shellfish, BULBUS FRITILLARIAE THUNBERGII, resemble shellfish, Mongolian claims Nuo Getu Ru Wusibu, Buddhist nun than savart, contains peimine (C
27H
45O
3N), peiminine (C
27H
43O
3N), the fragrant (C of Bulbus Fritillariae Uninbracteatae
27H
46O
3N) etc., nature and flavor are bitter, sweet, are slightly cold, and are usually used in treating phlegm heat cough, exogenous cough, cough due to yin deficiency, the few parched throat of expectorant, the diseases such as Huang is thick, lung abscess, acute mastitis, carbuncle pyogenic infections from tumour or sore, scrofula of coughing up phlegm.Rhizoma Coptidis is the dry rhizome of ranunculaceae plant Rhizoma Coptidis Coptis chinensis Franch. Coptis deltoidea C.Y.Cheng et Hsiao Coptis deltoidea C.Y.Chenget Hsiao or Coptis Teeta Wall Coptis teeta Wall., the another name flavor connects, Mongolian claims Xi La-Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), rather-Ba Ri, Lagotis clarkei Hook. F (Lagotis brevituba Maxim.)-Si Ribu, contains berberine (C
20H
19O
5N), Golden seal (C
19H
15O
5N), palmatine (C
21H
23O
5N), worenine (C
20H
17O
5N), nature and flavor bitter cold, but heat clearing and damp drying, eliminating fire and detoxication.The Radix Aucklandiae (Costustoot, Common Vladimiria Root) be the root of Compositae herbaceos perennial Saussurea lappa Clarke Aucklandia lappa Decne., Radix Vladimiriae Vladimiria souliei (Franch.) Ling, another name: honey perfume, Radix Aristolochiae, spices, five Radix Aucklandiae, Radix Aristolochiae yunnanensis, Radix Aucklandiae (Radix Vladimiriae), Saussurea lappa Clarke, Mongolian claim as reach, husky bubble as reach, the agate slave is as reaching, and contains constuslactone (C
15H
20O
2), costic acid (C
15H
22O
2), costol (C
15H
24O) etc., acrid in the mouth, bitterness temperature, but promoting the circulation of QI to relieve pain, transfer in intestinal stasis relieving, be usually used in treating born of the same parents and coerce distension, abdominal distention, tell and have loose bowels, heavily wait after dysentery.The said medicine synergism, receive altogether three seven elements of conditioning, go bag as, suppress uncommon and draw, dispel that Ba Da is xeothermic, the sticking merit of detoxifying, disappear, reach the stomachache of releiving, comprehensive gastric acid, improve digestive function, strengthen the stomach blood circulation, softening gastric deposit, promote ulcer convergence and even the purpose that heals.
Two, toxicity test: in acute toxicity testing research, at first measured the median lethal dose(LD 50) (LD50) of this mongolian medicine, but failed to measure its LD50, illustrated that this mongolian medicine acute toxicity is less.And then measure its maximum dosage-feeding: medicine is made into the Cmax that mice can be accepted, with the maximum volume gastric infusion, one day 3 times, observed 15 days.Dosage is pressed per weight and is calculated, and reaches 56 times of people's dosage, and death or other abnormal phenomenas do not appear in all mices, illustrate that its safety is very high.Put down in writing according to interrelated data, the Fructus Chebulae has certain toxicity, white mice LD50=500mg/kg, and this medicament calculates by people 50kg body weight, and medicine is with full pulverizing calculatings of being used as medicine, and Fructus Chebulae's maximum daily intaking amount only has 36mg/kg, belong to safety range, through producing the process of preparing Chinese medicine, its intake should be far below this numerical value, therefore can think safe.Put down in writing according to another data: Oletum Trogopterori easily injures one's stomach, and research on maximum utilized quantity 9g/ day, the maximum dose of this medicine Oletum Trogopterori is roughly equal to 3g/ day, belongs to safety range.
Three, zoopery: for verifying the therapeutical effect of this medicine; the inventor has carried out animal pharmacodynamics experimentation; result confirms that this mongolian medicine is remarkable to the protective effect of gastric mucosa, and the gastric ulcer model that stress ulcer disease model, ethanol are caused, the gastric ulcer model of pyloric ligation all have preventive effect.Experimental result is as follows:
1. on the impact of stress in rats gastric ulcer, the results are shown in Table 1
The impact of table 1 on the stress in rats gastric ulcer
Compare with model group, ranitidine group and high, medium and low 3 dosage group ulcer areas all obviously reduce, and there were significant differences (P＜0.05 or P＜0.01); Each administration group Area of ulcer has no obvious minimizing, without significant difference.
2. rat ethanol is caused the impact of gastric ulcer, the results are shown in Table 2:
Table 2 causes the impact of gastric ulcer on rat ethanol
Annotate: compare with model group
1)P＜0.05,
2)P＜0.01; Compare P＜0.05 with colloidal bismmth pectin.
Compare with model group, high, the middle dosage group Area of ulcer of colloidal bismmth pectin combination obviously reduces, and there were significant differences (P＜0.05), and the low dose group Area of ulcer has no minimizing, without significant difference; The colloidal bismmth pectin group, high, medium and low dosage group ulcer area obviously reduces, and there were significant differences (P＜0.01).
Compare with the colloidal bismmth pectin group, the high dose group Area of ulcer obviously reduces, and there were significant differences (P＜0.05); High dose group and middle dosage group ulcer area are less than the colloidal bismmth pectin group, and there were significant differences (P＜0.05), and the low dose group ulcer area is without significant difference.
3. the rat pylorus ligation is caused the impact of gastric ulcer, the results are shown in Table 3:
The impact of table 3 on rat gastric acid stomach function regulating proteinase activity
Annotate: compare with model group
1)P＜0.05.
Compare with model group, in KUIYANG SAN, low dosage obviously descends to the rat gastric ulcer total acidity gastric juice, there were significant differences (P＜0.05); The low dose group pepsin activity obviously reduces, and there were significant differences (P＜0.05).Each administration group free acid amount is without significant change, without significant difference.A mistake! Do not find Reference source.
Four, clinical experiment: since 2008, " internal medicine " that the Li Zhen suzerainty who published in 1999 according to the People's Health Publisher compiles provides diagnosis and treatment standard, the modern times such as the detection that employing gastroscopy, x-ray barium meal examination, HP infect, gastric analysis are made a definite diagnosis means, accept patient's many cases for medical treatment, adopt this pharmaceutical treatment, reaction is good.Only accepted patient's 66 examples for medical treatment, treatment situation such as following table in Tongliao, Inner Mongolia many, city hospital in 2012:
| Type | Number of cases | Cure | Produce effects | Invalid | Cure rate % | Total effective rate % |
| Gastric ulcer | 56 | 41 | 8 | 7 | 73.2 | 87.5 |
| Duodenal ulcer | 18 | 12 | 2 | 4 | 66.7 | 77.7 |
| Add up to | 74 | 53 | 10 | 11 | 74.2 | 85.1 |
Be limited to condition, direct contrast is not done in clinical experiment, but the first three years similar patient treatment situation of accepting for medical treatment is compared therewith, and the therapeutic effect of this medicine significantly strengthens.Particularly this medicine treatment cycle mostly was for 2-3 weeks, shortened on year-on-year basis 30% left and right, and the expenses for medicine cost is more than 40%.Followed up a case by regular visits to after healing 5 years, relapse rate is lower than 30%, and 5 years relapse rates that being starkly lower than interrelated data provides reach 50% statistical indicator, and find that not yet medication causes the case of other diseases, illustrate that this medicine has higher clinical value.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310128051.8A CN103169850B (en) | 2013-04-15 | 2013-04-15 | Mongolian medicine for treating peptic ulcer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310128051.8A CN103169850B (en) | 2013-04-15 | 2013-04-15 | Mongolian medicine for treating peptic ulcer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103169850A true CN103169850A (en) | 2013-06-26 |
| CN103169850B CN103169850B (en) | 2015-05-13 |
Family
ID=48630337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310128051.8A Expired - Fee Related CN103169850B (en) | 2013-04-15 | 2013-04-15 | Mongolian medicine for treating peptic ulcer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103169850B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106075272A (en) * | 2016-07-22 | 2016-11-09 | 内蒙古锡林郭勒盟蒙医医院 | A kind of mongolian medicine treating peptic ulcer and preparation method thereof |
| CN117837693A (en) * | 2024-03-07 | 2024-04-09 | 长春中医药大学 | A feed additive for preventing/treating gastric ulcer in pet mice and its application |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102188614A (en) * | 2009-05-27 | 2011-09-21 | 成仕孝 | Capsule for gastric ulcer |
| CN102671098A (en) * | 2012-05-15 | 2012-09-19 | 宋协勘 | Traditional Chinese medicine for treating peptic ulcer |
-
2013
- 2013-04-15 CN CN201310128051.8A patent/CN103169850B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102188614A (en) * | 2009-05-27 | 2011-09-21 | 成仕孝 | Capsule for gastric ulcer |
| CN102671098A (en) * | 2012-05-15 | 2012-09-19 | 宋协勘 | Traditional Chinese medicine for treating peptic ulcer |
Non-Patent Citations (1)
| Title |
|---|
| 吴七十三等: "蒙药验方溃疡散对实验性大鼠胃溃疡的作用", 《中国实验方剂学杂志》, vol. 19, no. 6, 31 March 2013 (2013-03-31), pages 257 - 259 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106075272A (en) * | 2016-07-22 | 2016-11-09 | 内蒙古锡林郭勒盟蒙医医院 | A kind of mongolian medicine treating peptic ulcer and preparation method thereof |
| CN106075272B (en) * | 2016-07-22 | 2020-06-19 | 内蒙古锡林郭勒盟蒙医医院 | Mongolian medicine for treating peptic ulcer and preparation method thereof |
| CN117837693A (en) * | 2024-03-07 | 2024-04-09 | 长春中医药大学 | A feed additive for preventing/treating gastric ulcer in pet mice and its application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103169850B (en) | 2015-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101972338B (en) | Chinese medicinal preparation for treating infantile upper respiratory tract infection and preparation method thereof | |
| CN104187172B (en) | Functional feed for treating enterogastritis diseases of turtles and preparation method of functional feed | |
| CN102526318A (en) | Chinese medicinal composition for preventing and treating chicken diseases and preparation method thereof | |
| CN104173937A (en) | Traditional Chinese medicine composition for dispersing stagnated liver qi for promoting bile flow and applications thereof | |
| CN102641366A (en) | Traditional Chinese medicine composition for preventing and treating proventriculitis and gizzard erosion of poultry | |
| CN101130023A (en) | Stomach warming codonopsis powder | |
| CN103705782A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN101468194B (en) | Medicine composition for treating colitis and method of making the same | |
| CN103054995A (en) | Pure Chinese medicinal composition for treating honeybee pupa disease and preparation method thereof | |
| CN103169850A (en) | Mongolian medicine for treating peptic ulcer | |
| CN105878930A (en) | Traditional Chinese medicine preparation for inhibiting hepatic metastasis of colonic carcinoma | |
| CN104001131A (en) | Oral traditional Chinese medicine for preventing and treating stress ulcers | |
| CN103566190A (en) | Traditional Chinese medicine composition for treating epigastric pain | |
| CN103040975B (en) | Traditional Chinese medicine composition for nursing and treating infantile diarrhea | |
| CN103405722B (en) | Chinese herba preparation for preventing and treating infantile cough | |
| CN105521332A (en) | Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof | |
| CN104547512B (en) | A kind of pharmaceutical composition for treating disease of pharynx and preparation method thereof | |
| CN104906472A (en) | Traditional Chinese medicine composition for preventing and treating cough-variant asthma | |
| CN103585580A (en) | Chinese medicinal preparation for treating recurrent oral ulceration | |
| CN101695534B (en) | Chinese patent medicament for treating mammary gland disease | |
| CN102430004B (en) | Traditional Chinese medicinal preparation for treating diarrhea | |
| CN106361902A (en) | Traditional Chinese medicine composition for preventing and treating livestock diarrhea and preparation method thereof | |
| CN105434670A (en) | Traditional Chinese medicine preparation for treating costal chondritis and preparation method thereof | |
| CN104800724B (en) | Improve the medicine of toxicity after chemotherapy of tumors | |
| CN104784608B (en) | Preparation method of medicine for improving toxic and side effects of tumor chemotherapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150513 |